| 9YB | Name: | (3~{R})-3-[[1-(2-hydroxyethyl)-5-[(4-methoxynaphthalen-1-yl)methyl]-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridin-3-yl]carbonylamino]-3-phenyl-propanoic acid | Formula: | C30 H32 N4 O5 | SMILES: | COc1ccc(CN2CCc3n(CCO)nc(C(=O)N[CH](CC(O)=O)c4ccccc4)c3C2)c5ccccc15 | InChi: | InChI=1S/C30H32N4O5/c1-39-27-12-11-21(22-9-5-6-10-23(22)27)18-33-14-13-26-24(19-33)29(32-34(26)15-16-35)30(38)31-25(17-28(36)37)20-7-3-2-4-8-20/h2-12,25,35H,13-19H2,1H3,(H,31,38)(H,36,37)/t25-/m1/s1 | Definition date: | 2017-08-01 | Last modified: | 2019-03-01 | Release date: | 2019-03-06 | Identifier: | (3~{R})-3-[[1-(2-hydroxyethyl)-5-[(4-methoxynaphthalen-1-yl)methyl]-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridin-3-yl]carbonylamino]-3-phenyl-propanoic acid |
|
| J3M | Name: | (2S)-tert-butoxy[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1-phenylisoquinolin-4-yl]acetic acid | Formula: | C30 H29 N O4 | SMILES: | c2(c(nc(c1ccccc1)c3ccccc23)c4ccc5c(c4)CCCO5)C(OC(C)(C)C)C(O)=O | InChi: | InChI=1S/C30H29NO4/c1-30(2,3)35-28(29(32)33)25-22-13-7-8-14-23(22)26(19-10-5-4-6-11-19)31-27(25)21-15-16-24-20(18-21)12-9-17-34-24/h4-8,10-11,13-16,18,28H,9,12,17H2,1-3H3,(H,32,33)/t28-/m0/s1 | Definition date: | 2018-08-06 | Last modified: | 2019-03-01 | Release date: | 2019-03-06 | Identifier: | (2S)-tert-butoxy[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1-phenylisoquinolin-4-yl]acetic acid |
|
| J3P | Name: | (2S)-[1-(1-benzyl-1H-pyrazol-4-yl)-3-(3,4-dihydro-2H-1-benzopyran-6-yl)isoquinolin-4-yl](tert-butoxy)acetic acid | Formula: | C34 H33 N3 O4 | SMILES: | c3(c(nc(c2cnn(Cc1ccccc1)c2)c4ccccc34)c5ccc6c(c5)CCCO6)C(OC(C)(C)C)C(=O)O | InChi: | InChI=1S/C34H33N3O4/c1-34(2,3)41-32(33(38)39)29-26-13-7-8-14-27(26)30(25-19-35-37(21-25)20-22-10-5-4-6-11-22)36-31(29)24-15-16-28-23(18-24)12-9-17-40-28/h4-8,10-11,13-16,18-19,21,32H,9,12,17,20H2,1-3H3,(H,38,39)/t32-/m0/s1 | Definition date: | 2018-08-06 | Last modified: | 2019-03-01 | Release date: | 2019-03-06 | Identifier: | (2S)-[1-(1-benzyl-1H-pyrazol-4-yl)-3-(3,4-dihydro-2H-1-benzopyran-6-yl)isoquinolin-4-yl](tert-butoxy)acetic acid |
|
| JDG | Name: | 2-cyclohexyl-7-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-8-[3-(pyrrolidin-1-yl)propoxy]-3H-1,4-benzodiazepin-5-amine | Formula: | C31 H49 N5 O2 | SMILES: | C1N(CCC1)CCCOc5c(cc2c(N=C(CN=C2NC3CCN(CC3)C(C)C)C4CCCCC4)c5)OC | InChi: | InChI=1S/C31H49N5O2/c1-23(2)36-17-12-25(13-18-36)33-31-26-20-29(37-3)30(38-19-9-16-35-14-7-8-15-35)21-27(26)34-28(22-32-31)24-10-5-4-6-11-24/h20-21,23-25H,4-19,22H2,1-3H3,(H,32,33) | Definition date: | 2018-08-31 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 2-cyclohexyl-7-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-8-[3-(pyrrolidin-1-yl)propoxy]-3H-1,4-benzodiazepin-5-amine |
|
| KUV | Name: | 5-amino-N-{5-[(4R,5R)-4-amino-5-fluoroazepan-1-yl]-1-methyl-1H-pyrazol-4-yl}-2-(2,6-difluorophenyl)-1,3-thiazole-4-carboxamide | Formula: | C20 H22 F3 N7 O S | SMILES: | n3(c(c(NC(c2nc(c1c(cccc1F)F)sc2N)=O)cn3)N4CCC(C(F)CC4)N)C | InChi: | InChI=1S/C20H22F3N7OS/c1-29-20(30-7-5-10(21)13(24)6-8-30)14(9-26-29)27-18(31)16-17(25)32-19(28-16)15-11(22)3-2-4-12(15)23/h2-4,9-10,13H,5-8,24-25H2,1H3,(H,27,31)/t10-,13-/m1/s1 | Definition date: | 2019-01-16 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 5-amino-N-{5-[(4R,5R)-4-amino-5-fluoroazepan-1-yl]-1-methyl-1H-pyrazol-4-yl}-2-(2,6-difluorophenyl)-1,3-thiazole-4-carboxamide |
|
| 862 | Name: | 1-[(3~{R})-3-[4-azanyl-3-[1-(4-ethanoylphenyl)-1,2,3-triazol-4-yl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one | Formula: | C23 H25 N9 O2 | SMILES: | CCC(=O)N1CCC[CH](C1)n2nc(c3cn(nn3)c4ccc(cc4)C(C)=O)c5c(N)ncnc25 | InChi: | InChI=1S/C23H25N9O2/c1-3-19(34)30-10-4-5-17(11-30)32-23-20(22(24)25-13-26-23)21(28-32)18-12-31(29-27-18)16-8-6-15(7-9-16)14(2)33/h6-9,12-13,17H,3-5,10-11H2,1-2H3,(H2,24,25,26)/t17-/m1/s1 | Definition date: | 2018-11-28 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-[(3~{R})-3-[4-azanyl-3-[1-(4-ethanoylphenyl)-1,2,3-triazol-4-yl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one |
|
| BXE | Name: | [3-(2~{H}-1,2,3,4-tetrazol-5-yl)propanoylamino]azanium | Formula: | C4 H9 N6 O | SMILES: | [NH3+]NC(=O)CCc1n[nH]nn1 | InChi: | InChI=1S/C4H8N6O/c5-6-4(11)2-1-3-7-9-10-8-3/h1-2,5H2,(H,6,11)(H,7,8,9,10)/p+1 | Definition date: | 2017-10-27 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | [3-(2~{H}-1,2,3,4-tetrazol-5-yl)propanoylamino]azanium |
|
| B2U | Name: | N-[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carbonyl]-D-phenylalanine | Formula: | C20 H18 Cl N O6 | SMILES: | c1ccccc1CC(C(O)=O)NC(=O)c3cc(Cl)c2CC(C)OC(c2c3O)=O | InChi: | InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15-/m1/s1 | Definition date: | 2019-01-09 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | N-[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carbonyl]-D-phenylalanine |
|
| F7Q | Name: | (2~{S})-2-azanyl-3-[1-(dioxidanyl)-4-oxidanylidene-cyclohexa-2,5-dien-1-yl]propanoic acid | Formula: | C9 H11 N O5 | SMILES: | N[CH](CC1(OO)C=CC(=O)C=C1)C(O)=O | InChi: | InChI=1S/C9H11NO5/c10-7(8(12)13)5-9(15-14)3-1-6(11)2-4-9/h1-4,7,14H,5,10H2,(H,12,13)/t7-/m0/s1 | Definition date: | 2018-06-07 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (2~{S})-2-azanyl-3-[1-(dioxidanyl)-4-oxidanylidene-cyclohexa-2,5-dien-1-yl]propanoic acid |
|
| G4Z | Name: | (1~{R})-2-(4-chloranylphenoxy)-2-methyl-1-[methyl(2-sulfanylethyl)amino]propan-1-ol | Formula: | C13 H20 Cl N O2 S | SMILES: | CN(CCS)[CH](O)C(C)(C)Oc1ccc(Cl)cc1 | InChi: | InChI=1S/C13H20ClNO2S/c1-13(2,12(16)15(3)8-9-18)17-11-6-4-10(14)5-7-11/h4-7,12,16,18H,8-9H2,1-3H3/t12-/m1/s1 | Definition date: | 2018-08-28 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (1~{R})-2-(4-chloranylphenoxy)-2-methyl-1-[methyl(2-sulfanylethyl)amino]propan-1-ol |
|
| G8Q | Name: | (1~{R},2~{S})-2-[methyl-[(~{R})-(2-methylpropan-2-yl)oxy-oxidanyl-methyl]amino]-2-phenyl-1-(2-sulfanylethylamino)ethanol | Formula: | C16 H28 N2 O3 S | SMILES: | CN([CH](O)OC(C)(C)C)[CH]([CH](O)NCCS)c1ccccc1 | InChi: | InChI=1S/C16H28N2O3S/c1-16(2,3)21-15(20)18(4)13(14(19)17-10-11-22)12-8-6-5-7-9-12/h5-9,13-15,17,19-20,22H,10-11H2,1-4H3/t13-,14+,15+/m0/s1 | Definition date: | 2018-09-06 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (1~{R},2~{S})-2-[methyl-[(~{R})-(2-methylpropan-2-yl)oxy-oxidanyl-methyl]amino]-2-phenyl-1-(2-sulfanylethylamino)ethanol |
|
| G8T | Name: | (1~{S})-2,2-diphenyl-1-(2-sulfanylethylamino)propan-1-ol | Formula: | C17 H21 N O S | SMILES: | CC([CH](O)NCCS)(c1ccccc1)c2ccccc2 | InChi: | InChI=1S/C17H21NOS/c1-17(16(19)18-12-13-20,14-8-4-2-5-9-14)15-10-6-3-7-11-15/h2-11,16,18-20H,12-13H2,1H3/t16-/m0/s1 | Definition date: | 2018-09-06 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (1~{S})-2,2-diphenyl-1-(2-sulfanylethylamino)propan-1-ol |
|
| GE8 | Name: | 2-(4-chloranylphenoxy)-2-methyl-~{N}-(3-sulfanylpropyl)propanamide | Formula: | C13 H18 Cl N O2 S | SMILES: | CC(C)(Oc1ccc(Cl)cc1)C(=O)NCCCS | InChi: | InChI=1S/C13H18ClNO2S/c1-13(2,12(16)15-8-3-9-18)17-11-6-4-10(14)5-7-11/h4-7,18H,3,8-9H2,1-2H3,(H,15,16) | Definition date: | 2018-09-13 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 2-(4-chloranylphenoxy)-2-methyl-~{N}-(3-sulfanylpropyl)propanamide |
|
| GEH | Name: | 2-(4-chloranylphenoxy)-2-methyl-~{N}-(2-sulfanylethyl)propanamide | Formula: | C12 H16 Cl N O2 S | SMILES: | CC(C)(Oc1ccc(Cl)cc1)C(=O)NCCS | InChi: | InChI=1S/C12H16ClNO2S/c1-12(2,11(15)14-7-8-17)16-10-5-3-9(13)4-6-10/h3-6,17H,7-8H2,1-2H3,(H,14,15) | Definition date: | 2018-09-13 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 2-(4-chloranylphenoxy)-2-methyl-~{N}-(2-sulfanylethyl)propanamide |
|
| GO8 | Name: | 8-propan-2-ylsulfanyl-7~{H}-purin-6-amine | Formula: | C8 H11 N5 S | SMILES: | CC(C)Sc1[nH]c2c(N)ncnc2n1 | InChi: | InChI=1S/C8H11N5S/c1-4(2)14-8-12-5-6(9)10-3-11-7(5)13-8/h3-4H,1-2H3,(H3,9,10,11,12,13) | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 8-propan-2-ylsulfanyl-7~{H}-purin-6-amine |
|
| GUK | Name: | 6-chloranyl-3-(2~{H}-indazol-5-yl)-~{N}-propan-2-yl-imidazo[1,2-b]pyridazin-8-amine | Formula: | C16 H15 Cl N6 | SMILES: | CC(C)Nc1cc(Cl)nn2c(cnc12)c3ccc4n[nH]cc4c3 | InChi: | InChI=1S/C16H15ClN6/c1-9(2)20-13-6-15(17)22-23-14(8-18-16(13)23)10-3-4-12-11(5-10)7-19-21-12/h3-9,20H,1-2H3,(H,19,21) | Definition date: | 2018-10-10 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 6-chloranyl-3-(2~{H}-indazol-5-yl)-~{N}-propan-2-yl-imidazo[1,2-b]pyridazin-8-amine |
|
| J8A | Name: | 3-{2-[(cyclopropanecarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}-N-{4-[(piperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide | Formula: | C29 H27 F3 N6 O2 S | SMILES: | c1cc(cc(c1)C(Nc3ccc(CN2CCNCC2)c(c3)C(F)(F)F)=O)c5ccc6nc(NC(=O)C4CC4)sc6n5 | InChi: | InChI=1S/C29H27F3N6O2S/c30-29(31,32)22-15-21(7-6-20(22)16-38-12-10-33-11-13-38)34-26(40)19-3-1-2-18(14-19)23-8-9-24-27(35-23)41-28(36-24)37-25(39)17-4-5-17/h1-3,6-9,14-15,17,33H,4-5,10-13,16H2,(H,34,40)(H,36,37,39) | Definition date: | 2018-08-22 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | 3-{2-[(cyclopropanecarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}-N-{4-[(piperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide |
|
| KSD | Name: | N-({2,6-dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl}methyl)-D-alanine | Formula: | C26 H29 N O5 | SMILES: | c3cc(COc1cc(OC)c(c(c1)OC)CNC(C(=O)O)C)c(C)c(c2ccccc2)c3 | InChi: | InChI=1S/C26H29NO5/c1-17-20(11-8-12-22(17)19-9-6-5-7-10-19)16-32-21-13-24(30-3)23(25(14-21)31-4)15-27-18(2)26(28)29/h5-14,18,27H,15-16H2,1-4H3,(H,28,29)/t18-/m1/s1 | Definition date: | 2019-01-11 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | N-({2,6-dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl}methyl)-D-alanine |
|
| KXP | Name: | (2S)-1-{[(R)-hydroxy{[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl icosa-5,8,11,14-tetraenoate | Formula: | C47 H85 O19 P3 | SMILES: | C(OC(CCCCCCCCCCCCCCCCC)=O)C(COP(=O)(O)OC1C(O)C(C(C(C1O)OP(O)(O)=O)OP(O)(O)=O)O)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC | InChi: | InChI=1S/C47H85O19P3/c1-3-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-36-41(49)63-39(37-61-40(48)35-33-31-29-27-25-23-21-18-16-14-12-10-8-6-4-2)38-62-69(59,60)66-45-42(50)43(51)46(64-67(53,54)55)47(44(45)52)65-68(56,57)58/h11,13,17,19,22,24,28,30,39,42-47,50-52H,3-10,12,14-16,18,20-21,23,25-27,29,31-38H2,1-2H3,(H,59,60)(H2,53,54,55)(H2,56,57,58)/t39-,42+,43-,44-,45+,46+,47+/m0/s1 | Definition date: | 2019-01-23 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | (2S)-1-{[(R)-hydroxy{[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl icosa-5,8,11,14-tetraenoate |
|
| KXS | Name: | (1R,2S,5R)-N-(4-methoxyphenyl)-5-methyl-2-(propan-2-yl)cyclohexane-1-carboxamide | Formula: | C18 H27 N O2 | SMILES: | c1c(ccc(c1)OC)NC(C2C(CCC(C)C2)C(C)C)=O | InChi: | InChI=1S/C18H27NO2/c1-12(2)16-10-5-13(3)11-17(16)18(20)19-14-6-8-15(21-4)9-7-14/h6-9,12-13,16-17H,5,10-11H2,1-4H3,(H,19,20)/t13-,16+,17-/m1/s1 | Definition date: | 2019-01-23 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | (1R,2S,5R)-N-(4-methoxyphenyl)-5-methyl-2-(propan-2-yl)cyclohexane-1-carboxamide |
|
| JR7 | Name: | N-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]propanamide | Formula: | C12 H11 Cl N2 O S | SMILES: | C(C)C(=O)Nc1scc(n1)c2ccc(Cl)cc2 | InChi: | InChI=1S/C12H11ClN2OS/c1-2-11(16)15-12-14-10(7-17-12)8-3-5-9(13)6-4-8/h3-7H,2H2,1H3,(H,14,15,16) | Definition date: | 2018-09-18 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | N-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]propanamide |
|
| JRD | Name: | N-[(3-methyl-1,2-oxazol-5-yl)methyl]-N-(4-phenyl-1,3-thiazol-2-yl)propanamide | Formula: | C17 H17 N3 O2 S | SMILES: | O=C(N(c2scc(c1ccccc1)n2)Cc3onc(C)c3)CC | InChi: | InChI=1S/C17H17N3O2S/c1-3-16(21)20(10-14-9-12(2)19-22-14)17-18-15(11-23-17)13-7-5-4-6-8-13/h4-9,11H,3,10H2,1-2H3 | Definition date: | 2018-09-18 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | N-[(3-methyl-1,2-oxazol-5-yl)methyl]-N-(4-phenyl-1,3-thiazol-2-yl)propanamide |
|
| JRM | Name: | methyl N-(4-phenyl-1,3-thiazol-2-yl)-N-propanoylglycinate | Formula: | C15 H16 N2 O3 S | SMILES: | n1c(N(CC(=O)OC)C(CC)=O)scc1c2ccccc2 | InChi: | InChI=1S/C15H16N2O3S/c1-3-13(18)17(9-14(19)20-2)15-16-12(10-21-15)11-7-5-4-6-8-11/h4-8,10H,3,9H2,1-2H3 | Definition date: | 2018-09-18 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | methyl N-(4-phenyl-1,3-thiazol-2-yl)-N-propanoylglycinate |
|
| G4H | Name: | ~{N}-[1-methyl-2-oxidanylidene-3-[1-[[4-(5-oxidanylidene-3-phenyl-6~{H}-1,6-naphthyridin-2-yl)phenyl]methyl]piperidin-4-yl]benzimidazol-5-yl]propanamide | Formula: | C37 H36 N6 O3 | SMILES: | CCC(=O)Nc1ccc2N(C)C(=O)N(C3CCN(CC3)Cc4ccc(cc4)c5nc6C=CNC(=O)c6cc5c7ccccc7)c2c1 | InChi: | InChI=1S/C37H36N6O3/c1-3-34(44)39-27-13-14-32-33(21-27)43(37(46)41(32)2)28-16-19-42(20-17-28)23-24-9-11-26(12-10-24)35-29(25-7-5-4-6-8-25)22-30-31(40-35)15-18-38-36(30)45/h4-15,18,21-22,28H,3,16-17,19-20,23H2,1-2H3,(H,38,45)(H,39,44) | Definition date: | 2018-08-28 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | ~{N}-[1-methyl-2-oxidanylidene-3-[1-[[4-(5-oxidanylidene-3-phenyl-6~{H}-1,6-naphthyridin-2-yl)phenyl]methyl]piperidin-4-yl]benzimidazol-5-yl]propanamide |
|
| G4N | Name: | ~{N}-[1-[[4-(5-oxidanylidene-3-phenyl-6~{H}-1,6-naphthyridin-2-yl)phenyl]methyl]piperidin-4-yl]-3-(propanoylamino)benzamide | Formula: | C36 H35 N5 O3 | SMILES: | CCC(=O)Nc1cccc(c1)C(=O)NC2CCN(CC2)Cc3ccc(cc3)c4nc5C=CNC(=O)c5cc4c6ccccc6 | InChi: | InChI=1S/C36H35N5O3/c1-2-33(42)38-29-10-6-9-27(21-29)35(43)39-28-16-19-41(20-17-28)23-24-11-13-26(14-12-24)34-30(25-7-4-3-5-8-25)22-31-32(40-34)15-18-37-36(31)44/h3-15,18,21-22,28H,2,16-17,19-20,23H2,1H3,(H,37,44)(H,38,42)(H,39,43) | Definition date: | 2018-08-28 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | ~{N}-[1-[[4-(5-oxidanylidene-3-phenyl-6~{H}-1,6-naphthyridin-2-yl)phenyl]methyl]piperidin-4-yl]-3-(propanoylamino)benzamide |
|